Global Seeg Depth Electrodes Market Overview

Global SEEG Depth Electrodes Market was valued at USD 23.22 Million in 2023 and is expected to reach USD 40.72 Million by the year 2032, at a CAGR of 6.44%.

Epilepsy is one of the most common neurological diseases worldwide, affecting around 50 million people of all ages around the world. The risk of premature death in people with epilepsy is up to three times that of the general population. The lives of people with epilepsy are often impacted by stigma, discrimination, and human rights violations. Stereo electroencephalography (SEEG) is an invasive surgical procedure used to determine the areas of the brain where epileptic seizures originate. Doctors place electrodes in specific areas of the brain that are monitored to pinpoint the source of the seizures. SEEG electrodes can be localized better, resulting in surgical resection and a good seizure outcome. The procedure is based on the stereotactic placement of several depth electrodes to capture cortical and subcortical structures without major craniotomies. In the case of SEEG, although based on stereotactic principles, the "stereo" of the SEEG primarily refers to the three-dimensional nature of the SEEG record. For each patient, the procedure for intracerebral electrode placement is adapted accordingly with previously recorded clinical, electrical and anatomical data to minimize complications. Although, SEEG Depth Electrode technology is fairly new and at the developing stage, it presents rapid growth and wide adoption worldwide. Technological advancement is the main reason for the discovery of SEEG electrodes. As the process of placing electrodes is minimally invasive, it is becoming more popular among patients thus, supporting the development of the SEEG depth electrodes market in the forecast period. 

Market Dynamics And Key Factors For SEEG Depth Electrodes Market:

Drivers:

Rising number of patients suffering from chronic neurological disorders:

• The SEEG Depth Electrode market has grown with the factors considering such as the rising occurrence of chronic and neurological diseases, increasing investment in the advanced technologies by leading biopharmaceutical companies with the singular focus to increase the efficacy rate with minimal surgical procedures. The rising number of chronic diseases in the world stimulates the demand to access advanced diagnosis and treatment. Currently, the healthcare sector is at a paradigm shift in terms of the adoption of advanced robotics and artificial intelligence in neurological diseases. Therefore, there has been a rapid increase in the adoption of novel technologies to treat neurological disorders. 
• The rising burden of chronic and neurological diseases acts as an essential driver for the growth of the SEEG Depth Electrode market. Neurological diseases are one of the major concerns among healthcare providers to prevent and treat in the world. As per the World Health Organization report on 'Neurological Disorders Public Health Challenges' published in 2020, Around 1000 disorders associated with the nervous system, including Alzheimer's and other dementias, migraine, epilepsy, tetanus, meningitis, Parkinson's disease, multiple sclerosis, poliomyelitis and othera. Therefore, the SEEG Depth Electrode market presents a cutting-edge approach to diagnose and treat such illnesses and create an impact in the healthcare sector.

Minimally Invasive Surgery:

• SEEG depth electrodes present the viability of using minimally invasive methods and electrodes for interpreting neural activity related to motor and sensory events. As experiential data showed in ECoG recordings, neural signals formed by SEEG electrodes are primarily phasic (transient) in nature, even during sustained motor tasks. The main driver of SEEG depth electrodes adoption is a minimally invasive treatment where electrodes can be implanted into the brain without major skull surgery, unlike the previous technique of craniotomy. SEEG depth electrodes provide minimal complications, less post-operative pain, and rehabilitation, and less hospital admit time. SEEG depth electrodes provide precise, targeted treatment for acute cases of epilepsy in different ages of the patient.

Restraints:

High Cost of Surgical Procedure:

• The high cost associated with the treatment procedures will hamper the expansion of the SEEG depth electrodes market over the forecast period. SEEG electrodes are the latest innovation in detecting epileptic zones. New techniques have high costs as the equipment required for the procedure is manufactured by a limited number of companies. Moreover, for a new company to start production of SEEG electrodes requires FDA clearance. As SEEG surgical process is risky, it takes a longer duration of time to get clearance from respective government authorities. In addition to the high cost, lack of awareness and fear of surgical procedures among individuals may also hinder the growth of the SEEG depth electrodes market during the projected period. 

Opportunities:

Government Support for Advanced Neurosurgical Treatments:

• The United States has nearly 3,000,000 patients suffering from epilepsy United States which costs $15.5 billion per year Also, The Parkinson’s Disease Foundation estimates about 1,000,000 patients in the United States suffering from Parkinson's disease with an added 60,000 patients diagnosed per year. Such a growing number of chronic diseases compelled the government to encourage the new treatment which is more effective and less suffering for the patients. New generation neuro treatment enables companies to use technologically advanced medical equipment in the treatment of neural-linked diseases. NeuroOne Medical Technologies received clearance 510k from US Food and Drug Administration (FDA) for their new EvoSEEG Electrode technology which enables to promote of the Evo SEEG Electrodes for temporary use with recording, monitoring, and simulation equipment at the subsurface level of the brain. SEEG electrodes treatment is a less invasive process and avoids the removal of the frontal part of the patient’s skull. Such advanced robotic-based precise medical machinery holds a great opportunity for the safe and effective treatment of chronic diseases.

Challenges:

A limited number of Healthcare Professionals:

• The main challenge in the SEEG Depth Electrode market is the limited neurosurgeon and epileptologists who are experts in SEEG Depth Electrode treatment and lack of training to a staffer in the dedicated SEEG centers. According to the survey of Stereotactic EEG (SEEG) Practices, A Survey of United States Level 4 Epilepsy Centers from Baylor college of medicine suggests that over 51% of Faculty had prior experience at an SEEG center and 40% of neurosurgeons and 52% of epileptologist are certified with the training course. The majority of the SEEG dedicated centers lack implant planning protocol, electrode nomenclature, technical aspects of SEEG. 

Market Segmentation:

Segmentation Analysis of SEEG Depth Electrodes Market:

• Depending on the number of contact points, the above 12 segments are forecasted to record the highest share of the SEEG depth electrodes market. The number of electrodes depends on the age of the patient and the condition of the patient whether he or she can describe the different parts of the seizure. In addition, with more points of contact, the healthcare provider can precisely locate the area of the brain responsible for seizures. More contact points can generate more data, thus helping in proper diagnosing of the epileptogenic zone. Stereotactic EEG Practices conducted a survey of United States Tertiary Referral Epilepsy Centers, in which they found out that in more than 53% of patients an average of 11-15 SEEG electrodes were used thus, supporting the development of the segment. 
• Depending on people, the adult segment is anticipated to dominate the SEEG depth electrodes market over the projected period. SEEG electrodes are mostly used on adults mainly due to adults can describe their auras and can cooperate during electrical stimulations, for instance, by describing the different parts of the seizure. Bone thickness is the main criterion in determining if the SEEG procedure is feasible in very young patients because very thin skull bone predisposes them to risks such as hollow peg secondary mobilization or bone effraction by the stereotactic frame pin holders thus, these procedures are more suitable for the adult population. Moreover, the growing awareness of minimally invasive surgery among adults has escalated the demand for SEEG electrodes. 
• Depending on the application, the pre-surgical diagnosis segment is expected to lead the SEEG depth electrodes market in the analysis period. Stereo electroencephalography (SEEG) is a diagnostic method for patients with refractory focal epilepsies that are performed to localize and define the epileptogenic zone. SEEG electrodes, unlike grid electrodes, are placed utilizing minimally invasive surgical procedures that do not require massive craniotomies. This leads to fewer complications, less post-operative pain, and a shorter length of stay in the hospital. Epilepsy monitoring using SEEG before epilepsy surgery can assist locate the specific site of seizure activity in individuals with difficult-to-treat seizures.

Regional Analysis of SEEG Depth Electrodes Market:

• The North American region is forecasted to have the highest share of the SEEG depth electrodes market during the forecasted timeframe. The United States is the main headquarters where most of the prominent companies involved in the manufacturing of SEEG electrodes are based. Moreover, the countries in the North American region spend the most on healthcare infrastructure. Individuals in this region are well aware of the benefits of the SEEG surgical procedure for the treatment of epilepsy. According to CDC, about 470,000 children and 3 million adults in the United States have active epilepsy. With the growing life expectancy in this region, the causes of epilepsy are expected to increase in the coming future, thus the demand for SEEG depth electrodes will rise in the projected timeframe.
• The SEEG depth electrodes market in the Europe region is anticipated to grow at a positive growth rate in the analysis period. The growing inclination towards advanced medical treatments and the presence of top-class research institutes are the two main factors strengthening the development of the market in this region. According to Epilepsy Research UK, there are over 600,000 known cases of epilepsy. About 600 individuals are getting diagnosed with epilepsy and 21 epilepsy-related deaths every week in the UK. Additionally, the cost of epilepsy on the National Health Society is estimated to be US$ 1.7 billion annually. 
• The SEEG depth electrodes market in the Asia-Pacific region is forecasted to expand at the highest CAGR attributed to the growing prevalence of epilepsy in low- and middle-income countries (LMIC). According to WHO, nearly 80% of the total population suffering from epilepsy resides in the LMIC. The negligence towards diagnosis has resulted in huge treatment gaps which is more than 75% in most low-income countries and 50% in most middle-income countries. This is despite the effectiveness and low cost of antiseizure medications. Furthermore, 139 per 100,000 persons-year are diagnosed with epilepsy in LMIC regions. Thus, the rising cases and the growing inclination of patients towards minimally invasive surgical procedures are expected to propel the growth of the market in this region.  

Top Key Players Covered in Seeg Depth Electrodes Market:

• Ad-Tech Medical Instrument Corporation (US)
• DIXI Medical (France)
• PMT Corporation (US)
• NeuroOne (US)
• Integra LifeSciences (US)
• Natus Medical Incorporated (US)
• NeuroPace Inc. (US) and other major players.
• Inomed Medizintechnik GmbH
• Medtronic Plc
• Alcis
• Shaanxi Magang Medical Instrument Co., Ltd
• Mikromed
• Unique Medical Co., Ltd

Key Industry Developments In SEEG Depth Electrodes Market:

• In June 2024, DIXI Medical demonstrated its commitment to advancing SEEG education by supporting the continuing and specialized training of healthcare professionals in epilepsy. This year, the company organized courses across the United States and expanded into Asia, while also sponsoring international SEEG training programs worldwide. Over 300 epilepsy specialists across North and South America, Europe, and Asia benefited from DIXI Medical's support for these educational initiatives, highlighting its dedication to providing quality learning opportunities to a diverse range of professionals.
• In June 2024, NeuroOne Medical Technologies Corporation a medical technology company focused on enhancing surgical care options and outcomes for patients with neurological disorders, announced that the Centers for Medicare and Medicaid Services (CMS) approved a new ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure Coding System) code for the OneRF™ Ablation procedure.